TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback